Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gartrell

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Nature Reviews. Clinical Oncology|May 14, 2014
Managing bone metastases and reducing skeletal related events in prostate cancerBenjamin A Gartrell, Fred Saad
Expert Opinion on Emerging Drugs|November 8, 2013
Emerging drugs for urothelial carcinomaBenjamin A Gartrell, Guru Sonpavde
Therapeutic Advances in Urology|October 8, 2015
Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapyBenjamin A Gartrell, Fred Saad
Current Opinion in Urology|August 29, 2014
Pathologic fracture in patients with metastatic prostate cancerBenjamin A Gartrell, Fred Saad
Expert Opinion on Emerging Drugs|May 31, 2017
Emerging drugs for urothelial (bladder) cancerKerwin Cumberbatch, Tianfang He, Zachary Thorogood, et al.
Urologic Oncology|April 20, 2012
The follicle-stimulating hormone receptor: a novel target in genitourinary malignanciesBenjamin A Gartrell, Che-kai Tsao, Matthew D Galsky
Urologic Oncology|October 29, 2017
Update of systemic immunotherapy for advanced urothelial carcinomaBenjamin A Gartrell, Tianfang He, Janaki Sharma, et al.
Orthopedics|June 2, 1998
Postoperative epidural analgesia for pediatric spine surgeryD M Arms, J T Smith, J Osteyee, et al.
Investigational New Drugs|May 4, 2017
Impressive and durable response to nivolumab in a patient with metastatic type 2 papillary renal cell carcinoma: On-label but without evidenceDiego A Adrianzen Herrera, Sarah B Fleisig, Benjamin A Gartrell
Expert Review of Anticancer Therapy|December 21, 2012
Emerging personalized approaches for the management of advanced urothelial carcinomaChe-Kai Tsao, Benjamin A Gartrell, William K Oh, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Nature Reviews. Clinical Oncology|May 14, 2014
Managing bone metastases and reducing skeletal related events in prostate cancerBenjamin A Gartrell, Fred Saad
Expert Opinion on Emerging Drugs|November 8, 2013
Emerging drugs for urothelial carcinomaBenjamin A Gartrell, Guru Sonpavde
Therapeutic Advances in Urology|October 8, 2015
Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapyBenjamin A Gartrell, Fred Saad
Current Opinion in Urology|August 29, 2014
Pathologic fracture in patients with metastatic prostate cancerBenjamin A Gartrell, Fred Saad
Expert Opinion on Emerging Drugs|May 31, 2017
Emerging drugs for urothelial (bladder) cancerKerwin Cumberbatch, Tianfang He, Zachary Thorogood, et al.
Urologic Oncology|April 20, 2012
The follicle-stimulating hormone receptor: a novel target in genitourinary malignanciesBenjamin A Gartrell, Che-kai Tsao, Matthew D Galsky
Urologic Oncology|October 29, 2017
Update of systemic immunotherapy for advanced urothelial carcinomaBenjamin A Gartrell, Tianfang He, Janaki Sharma, et al.
Orthopedics|June 2, 1998
Postoperative epidural analgesia for pediatric spine surgeryD M Arms, J T Smith, J Osteyee, et al.
Investigational New Drugs|May 4, 2017
Impressive and durable response to nivolumab in a patient with metastatic type 2 papillary renal cell carcinoma: On-label but without evidenceDiego A Adrianzen Herrera, Sarah B Fleisig, Benjamin A Gartrell
Expert Review of Anticancer Therapy|December 21, 2012
Emerging personalized approaches for the management of advanced urothelial carcinomaChe-Kai Tsao, Benjamin A Gartrell, William K Oh, et al.
Pageof 5